bluewillow.comHealthcare / BioTech & PharmaFounded: 2000Funding to Date: $37.19MM
BlueWillow Biologics (also known as NanoBio) are the developer of intranasal vaccines that help protect global populations from food allergies, sexually transmitted diseases and respiratory infections. This company was founded in 2000 by James Baker and is headquartered in Ann Arbor, MI. BlueWillow's antiseptic and anti-infective products as well as NanoVax are using a patented nanotechnology platform to administrate nano-droplets to the skin and nose.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
09/19/2022 | Series C | $5.9MM | $xx.xx | $34.12MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
63,972,394
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.5x
Conversion Ratio
1.0x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Undisclosed Investors
|
||||||
03/31/2020 | Series B | $9.95MM | $xx.xx | $39.69MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
58,523,651
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Undisclosed Investors
|
||||||
05/07/2018 | Series A | $9.23MM | $xx.xx | $17.79MM | North Coast Technology Investors, Line Moon Ventures, University of Michigan | |
Price per Share
$xx.xx
Shares Outstanding
84,965,147
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
North Coast Technology Investors, Line Moon Ventures, University of Michigan
|
||||||
11/28/2012 | Series A-1 | $12.11MM | $xx.xx | $30.27MM | Perseus, Venture Investors | |
Price per Share
$xx.xx
Shares Outstanding
29,629,421
Liquidation Pref Order
4
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Perseus, Venture Investors
|